国外医学(医学地理分册)
國外醫學(醫學地理分冊)
국외의학(의학지리분책)
FOREIGN MEDICAL SCIENCES(SECTION OF MEDGEOGRAPHY)
2014年
3期
189-193
,共5页
王美晨%王璇%蓝茜%李玥%刘莉%伊静%李靖%宋刘梅%马莎蕊%宁启兰%李冬民
王美晨%王璇%藍茜%李玥%劉莉%伊靜%李靖%宋劉梅%馬莎蕊%寧啟蘭%李鼕民
왕미신%왕선%람천%리모%류리%이정%리정%송류매%마사예%저계란%리동민
胰岛素受体 mRNA 3′UTR区%pmirGLO 报告基因载体%目的片段%重组载体
胰島素受體 mRNA 3′UTR區%pmirGLO 報告基因載體%目的片段%重組載體
이도소수체 mRNA 3′UTR구%pmirGLO 보고기인재체%목적편단%중조재체
insulin receptor mRNA 3′UTR region%pmirGLO report gene carrier%purpose fragment%reorgani-zation of the carrier
目的:利用 pmirGLO Dual-Luciferase miRNA Target Expression Vector(简称为pmirGLO 报告基因载体)构建并鉴定含 miR-497野生及突变结合位点的胰岛素受体 mRNA 3′UTR 区报告基因载体(pmir-Insr-3′UTR 及 pmir-mutant-Insr-3′UTR)。方法以大鼠肝脏 cDNA为模板,PCR 获取目的片段(即含 miR-497野生及突变结合位点的胰岛素受体 mRNA 3′UTR区);用PmeI、XbaI双酶切 pmirGLO 报告基因载体和含 miR-497野生及突变结合位点的胰岛素受体 mRNA 3′UTR区,用T4 DNA连接酶连接纯化后的酶切产物;连接产物转化DH5α大肠杆菌感受态细胞并挑选阳性克隆,并通过PCR、双酶切、DNA测序鉴定构建的重组质粒。结果 PCR和双酶切证实pmir-Insr-3′UTR及 pmir-mutant-Insr-3′UTR重组载体中均插入目的片段;DNA测序结果进一步证实 pmir-Insr-3′UTR重组载体中成功插入了胰岛素受体mRNA 3′UTR区,pmir-mutant-Insr-3′UTR重组载体中成功插入了在miR-497结合位点含有3个突变碱基的胰岛素受体 mRNA 3′UTR 片段。结论成功构建了含 miR-497野生及突变结合位点的胰岛素受体mRNA 3′UTR报告基因载体 pmir-Insr-3′UTR及 pmir-mutant-Insr-3′UTR。
目的:利用 pmirGLO Dual-Luciferase miRNA Target Expression Vector(簡稱為pmirGLO 報告基因載體)構建併鑒定含 miR-497野生及突變結閤位點的胰島素受體 mRNA 3′UTR 區報告基因載體(pmir-Insr-3′UTR 及 pmir-mutant-Insr-3′UTR)。方法以大鼠肝髒 cDNA為模闆,PCR 穫取目的片段(即含 miR-497野生及突變結閤位點的胰島素受體 mRNA 3′UTR區);用PmeI、XbaI雙酶切 pmirGLO 報告基因載體和含 miR-497野生及突變結閤位點的胰島素受體 mRNA 3′UTR區,用T4 DNA連接酶連接純化後的酶切產物;連接產物轉化DH5α大腸桿菌感受態細胞併挑選暘性剋隆,併通過PCR、雙酶切、DNA測序鑒定構建的重組質粒。結果 PCR和雙酶切證實pmir-Insr-3′UTR及 pmir-mutant-Insr-3′UTR重組載體中均插入目的片段;DNA測序結果進一步證實 pmir-Insr-3′UTR重組載體中成功插入瞭胰島素受體mRNA 3′UTR區,pmir-mutant-Insr-3′UTR重組載體中成功插入瞭在miR-497結閤位點含有3箇突變堿基的胰島素受體 mRNA 3′UTR 片段。結論成功構建瞭含 miR-497野生及突變結閤位點的胰島素受體mRNA 3′UTR報告基因載體 pmir-Insr-3′UTR及 pmir-mutant-Insr-3′UTR。
목적:이용 pmirGLO Dual-Luciferase miRNA Target Expression Vector(간칭위pmirGLO 보고기인재체)구건병감정함 miR-497야생급돌변결합위점적이도소수체 mRNA 3′UTR 구보고기인재체(pmir-Insr-3′UTR 급 pmir-mutant-Insr-3′UTR)。방법이대서간장 cDNA위모판,PCR 획취목적편단(즉함 miR-497야생급돌변결합위점적이도소수체 mRNA 3′UTR구);용PmeI、XbaI쌍매절 pmirGLO 보고기인재체화함 miR-497야생급돌변결합위점적이도소수체 mRNA 3′UTR구,용T4 DNA련접매련접순화후적매절산물;련접산물전화DH5α대장간균감수태세포병도선양성극륭,병통과PCR、쌍매절、DNA측서감정구건적중조질립。결과 PCR화쌍매절증실pmir-Insr-3′UTR급 pmir-mutant-Insr-3′UTR중조재체중균삽입목적편단;DNA측서결과진일보증실 pmir-Insr-3′UTR중조재체중성공삽입료이도소수체mRNA 3′UTR구,pmir-mutant-Insr-3′UTR중조재체중성공삽입료재miR-497결합위점함유3개돌변감기적이도소수체 mRNA 3′UTR 편단。결론성공구건료함 miR-497야생급돌변결합위점적이도소수체mRNA 3′UTR보고기인재체 pmir-Insr-3′UTR급 pmir-mutant-Insr-3′UTR。
Objective To construct and identify the reporter gene vectors of the 3′UTR region of insulin re-ceptor mRNA containing the wild or mutant miR-497 binding site (pmir-Insr-3′UTR and pmir-mutant-Insr-3′UTR) using pmirGLO dual-Luciferase miRNA target expression vector (pmirGLO report gene vector).Methods The target fragments,which were the 3′UTR region of rat insulin receptor mRNA,including wild or mutant miR-497 binding site,were obtained by PCR using rat liver cDNA as template.The target fragments and pmirGLO report gene vector were cut by PmeI and XbaI restriction endonucleases and then the purified enzyme-digested products were ligated together with a T4 DNA ligase.Subsequently,the ligation productions were used to transform DH5αcompetent cells,and the positive clones were picked up from the agarose plate with ampicillin.Finally,the recombi-nant plasmids were identified through PCR,double-restrict-enzyme digestion of PmeI and XbaI and DNA sequence. Results PCR and double-restrict-enzyme digestion of PmeI and XbaI confirmed that the recombinant vectors of pmir-Insr-3′UTR and pmir-mutant-Insr-3′UTR successfully inserted into the target fragment respectively.The anal-ysis of DNA sequence further confirmed that pmir-Insr-3′UTR successfully inserted the 3′UTR region of rat insulin receptor mRNA,and pmir-mutant-Insr-3′UTR successfully inserted the 3’UTR region of rat insulin receptor mRNA containing three base mutation in miR-497 binding site.Conclusion We successfully constructed pmir-Insr-3′UTR and pmir-mutant-Insr-3′UTR,the reporter gene vectors of the 3′UTR region of insulin receptor mRNA containing wild or mutant miR-497 binding site.